News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
695,417 Results
Type
Article (58453)
Company Profile (159)
Press Release (636805)
Multimedia
Podcasts (81)
Webinars (13)
Section
Business (190677)
Career Advice (2781)
Deals (34721)
Drug Delivery (105)
Drug Development (79001)
Employer Resources (160)
FDA (16023)
Job Trends (14930)
News (328743)
Policy (31199)
Tag
Academia (2782)
Academic (2)
Accelerated approval (6)
Adcomms (24)
Allergies (92)
Alliances (49772)
ALS (95)
Alzheimer's disease (1350)
Antibody-drug conjugate (ADC) (138)
Approvals (16025)
Artificial intelligence (301)
Autoimmune disease (25)
Automation (16)
Bankruptcy (317)
Best Places to Work (11692)
BIOSECURE Act (21)
Biosimilars (105)
Biotechnology (108)
Bladder cancer (79)
Brain cancer (28)
Breast cancer (288)
Cancer (2310)
Cardiovascular disease (175)
Career advice (2361)
Career pathing (33)
CAR-T (164)
Cell therapy (456)
Cervical cancer (21)
Clinical research (64126)
Collaboration (904)
Company closure (2)
Compensation (389)
Complete response letters (21)
COVID-19 (2635)
CRISPR (47)
C-suite (270)
Cystic fibrosis (105)
Data (2285)
Decentralized trials (1)
Denatured (32)
Depression (48)
Diabetes (259)
Diagnostics (6616)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (40)
Drug discovery (128)
Drug pricing (105)
Drug shortages (26)
Duchenne muscular dystrophy (88)
Earnings (68986)
Editorial (42)
Employer branding (19)
Employer resources (139)
Events (106078)
Executive appointments (777)
FDA (17413)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (782)
Gene editing (119)
Generative AI (27)
Gene therapy (315)
GLP-1 (692)
Government (4607)
Grass and pollen (6)
Guidances (147)
Healthcare (19162)
Huntington's disease (20)
IgA nephropathy (23)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2776)
Inflammatory bowel disease (147)
Inflation Reduction Act (8)
Influenza (54)
Intellectual property (100)
Interviews (527)
IPO (15825)
IRA (41)
Job creations (3664)
Job search strategy (1980)
Kidney cancer (10)
Labor market (37)
Layoffs (520)
Leadership (21)
Legal (7138)
Liver cancer (73)
Lung cancer (316)
Lymphoma (149)
Machine learning (9)
Management (56)
Manufacturing (313)
MASH (72)
Medical device (14025)
Medtech (14030)
Mergers & acquisitions (19488)
Metabolic disorders (672)
Multiple sclerosis (81)
NASH (16)
Neurodegenerative disease (89)
Neuropsychiatric disorders (27)
Neuroscience (1898)
NextGen: Class of 2025 (6733)
Non-profit (4484)
Now hiring (21)
Obesity (340)
Opinion (248)
Ovarian cancer (80)
Pain (97)
Pancreatic cancer (85)
Parkinson's disease (145)
Partnered (21)
Patents (248)
Patient recruitment (118)
Peanut (50)
People (60603)
Pharmaceutical (35)
Pharmacy benefit managers (16)
Phase I (20329)
Phase II (28365)
Phase III (20639)
Pipeline (1327)
Policy (146)
Postmarket research (2415)
Preclinical (8758)
Press Release (69)
Prostate cancer (110)
Psychedelics (31)
Radiopharmaceuticals (263)
Rare diseases (378)
Real estate (6325)
Recruiting (64)
Regulatory (21603)
Reports (34)
Research institute (2528)
Resumes & cover letters (415)
Rett syndrome (5)
RNA editing (3)
RSV (38)
Schizophrenia (71)
Series A (140)
Series B (90)
Service/supplier (12)
Sickle cell disease (53)
Special edition (12)
Spinal muscular atrophy (151)
Sponsored (29)
Startups (3678)
State (2)
Stomach cancer (10)
Supply chain (59)
Tariffs (35)
The Weekly (47)
Vaccines (711)
Venture capitalists (38)
Weight loss (217)
Women's health (31)
Worklife (20)
Date
Last 7 days (911)
Last 30 days (2896)
Last 365 days (31735)
2025 (11549)
2024 (34304)
2023 (38936)
2022 (49911)
2021 (54871)
2020 (53760)
2019 (47560)
2018 (36210)
2017 (32896)
2016 (32416)
2015 (38169)
2014 (30968)
2013 (27080)
2012 (28679)
2011 (28968)
2010 (27314)
Location
Africa (909)
Alabama (57)
Alaska (7)
Arizona (200)
Arkansas (13)
Asia (41316)
Australia (7691)
California (6033)
Canada (1977)
China (524)
Colorado (269)
Connecticut (281)
Delaware (159)
Europe (94263)
Florida (914)
Georgia (216)
Idaho (59)
Illinois (577)
India (27)
Indiana (302)
Iowa (9)
Japan (172)
Kansas (108)
Kentucky (24)
Louisiana (11)
Maine (61)
Maryland (912)
Massachusetts (4462)
Michigan (241)
Minnesota (410)
Mississippi (2)
Missouri (90)
Montana (31)
Nebraska (23)
Nevada (65)
New Hampshire (70)
New Jersey (1754)
New Mexico (29)
New York (1752)
North Carolina (999)
North Dakota (8)
Northern California (2643)
Ohio (203)
Oklahoma (15)
Oregon (36)
Pennsylvania (1335)
Puerto Rico (13)
Rhode Island (29)
South America (1241)
South Carolina (26)
South Dakota (1)
Southern California (2286)
Tennessee (101)
Texas (915)
United States (23123)
Utah (187)
Virginia (146)
Washington D.C. (59)
Washington State (562)
West Virginia (3)
Wisconsin (63)
695,417 Results for "royal melbourne institute of technology rmit".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Oblique Therapeutics and the KTH Royal Institute of Technology (KTH) have entered into a strategic collaboration to analyse protein structures using supercomputers
Oblique Therapeutics, a leading biotechnology company specialising in the development of new drug candidates, is pleased to announce today that they have entered into an agreement with the KTH Royal Institute of Technology to utilise KTH’s state-of-the-art supercomputer resources for analysing protein structures.
June 18, 2024
·
3 min read
Press Releases
Alveo Technologies and Royal GD Form Long-Term Partnership to Expand Joint Offerings for Rapid, Molecular Animal Diagnostics at Point-of-Need
February 26, 2025
·
5 min read
Press Releases
Xcell Biosciences and Royal Perth Hospital to Develop Next Gen Automated TIL Manufacturing Workflow
March 19, 2025
·
3 min read
Press Releases
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 4, 2025
·
6 min read
Press Releases
Transverse Medical Inc. Announces Completion of First Series of Patients in Feasibility Clinical Study at Victorian Heart Hospital, Melbourne, Australia, Using Point-Guard Cerebral Embolic Protection.
April 21, 2025
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office
Amsterdam, the Netherlands – Royal Philips, a global leader in health technology, announced that it is one of the leading patent applicants at the European Patent Office.
March 19, 2024
·
2 min read
Press Releases
Telix Appoints Paul Schaffer as Chief Technology Officer
April 8, 2025
·
6 min read
Press Releases
Gelteq Appoints Dr. Paul Wynne as Chief Scientific Officer to Propel Innovative Ingestible Gel Technology
December 19, 2024
·
4 min read
Press Releases
Colossal Foundation Donates $1.5M USD to the University of Melbourne to Support Avian Conservation
November 20, 2024
·
5 min read
1 of 69,542
Next
